key: cord-0033738-awjxtn9h authors: nan title: References date: 2009-10-28 journal: Bone Marrow Transplant DOI: 10.1038/bmt.2009.269 sha: 2c8fdac6cc46f329dbbd3a060324105aa99bcd22 doc_id: 33738 cord_uid: awjxtn9h nan Prospective randomized placebo-controlled study of granulocytemacrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma. Transfusion-transmitted malaria: current donor selection guidelines are not sufficient Documented cases of posttransfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines Probable transfusiontransmitted malaria Transfusiontransmitted malaria in the United States from 1963 through 1999 Transfusion-transmitted malaria-Missouri and Pennsylvania Plasmodium falciparum infection following allogeneic bone-marrow transplantation Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period Transfusiontransmitted babesiosis in Ontario: first reported case in Canada Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California Transfusionassociated transmission of babesiosis in New York state Tick-borne diseases in transfusion medicine The impact of babesiosis on transfusion medicine Standards for Blood Banks and Transfusion Services Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis Blood donor screening for chagas disease-United States Centers for Disease Control and Prevention. Chagas disease after organ transplantation Chagas disease after organ transplantation-United States Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors Transmission of parasites by blood transfusion Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey National Marrow Donor Program. Donor Health History Screening Questionnaire. National Marrow Donor Program: Minneapolis Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products Microbial pathogens of hematopoietic stem cells-screening and testing for infectious diseases Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive to Infection in the Compromised Host A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced-and conventional-intensity conditioning regimens Aerobic bacterial and fungal infections in peripheral blood stem cell transplants Hickman catheter site infections after allogeneic stem cell transplantation: single-center experience Catheterassociated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion An intervention to decrease catheter-related bloodstream infections in the ICU Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial Clinical experience with minocycline and rifampinimpregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention Gauze and tape and transparent polyurethane dressings for central venous catheters Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution Ethanol lock therapy to treat tunnelled central venous catheterassociated blood stream infections: results from a prospective trial The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies American Academy of Pediatrics/Committee on Infectious Diseases. Pneumococcal infections. In: Pickering LK Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation Influence of immunisation timing on the response to conjugate-pneumococcal vaccine after allogeneic stem cell transplant: final results of the EBMT IDWP01 Trial Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma Pneumococcal pericarditis with cardiac tamponade in a patient with chronic graft-versus-host disease Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4 Dental management of patients with bone marrow and solid organ transplantation Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis In vitro activities of 22 beta-lactam antibiotics against penicillinresistant and penicillin-susceptible viridans group streptococci isolated from blood Viridans streptococcal shock in bone marrow transplantation patients Haemophilus influenzae infections. In: LK Pickering Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients Infections in bone marrow transplant recipients Pertussis in adolescence after unrelated cord blood transplantation Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Epstein-Barr virus lymphoproliferation after bone marrow transplantation Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-celldepleted SCT Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant A phase I-II trial to examine the toxicity of CMV-and EBVspecific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation Acyclovir prophylaxis of herpes-simplex-virus infections Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation Hepatitis due to herpes simplex virus in marrow-transplant recipients Use of longterm suppressive acyclovir after hematopoietic stem-cell transplantation: impact on Herpes simplex virus (HSV) disease and drug-resistant HSV disease (hydroxymethyl)ethoxyl]-methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2 Development of drug-resistant Herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation Transferred Herpes simplex virus immunity after stem-cell transplantation: clinical implications Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation Pediatric uses of valacyclovir, penciclovir and famciclovir Infectious Diseases, 26th edn Report of the Committee on Infectious Diseases Fields Virology. Lippincott, Williams and Wilkins: Philadelphia Characterization of human proliferative T cell responses to adenovirus Adenovirus infections in adult recipients of blood and marrow transplants Adenovirus infections in hematopoietic stem cell transplant recipients Adenovirus infections in transplant recipients Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease Increasing incidence of adenovirus disease in bone marrow transplant recipients Adenovirus infections in patients undergoing bone-marrow transplantation Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath) Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab Treatment of adenovirus disease in stem cell transplant recipients with cidofovir Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir In vitro susceptibility of adenovirus to antiviral drugs is species-dependent Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV) Polyomavirus BK (BKV) and JC (JCV) replication in plasma and urine in healthy blood donors (abstract no. 1058) Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants BK and JC virus infections in recipients of bone marrow transplants Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients Polyoma virus-associated interstitial nephritis in a patient with acute myeloic leukaemia and peripheral blood stem cell transplantation Polyomavirus nephropathy in native kidneys of non-renal transplant recipients Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid Antivirals for the treatment of polyomavirus BK replication Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer Hepatitis B virus DNA contains a glucocorticoid-responsive element Rituximab-related viral infections in lymphoma patients Lamivudine prophylaxis and treatment of hepatitis B Virusexposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up Long-term outcome of hepatitis C infection after bone marrow transplantation Hepatitis C virus serum markers and liver disease in children with leukemia Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation Review article: management of hepatic disease following haematopoietic cell transplant Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients Identification of human herpesvirus-6 as a causal agent for exanthem subitum Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation A population-based study of primary human herpesvirus 6 infection Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients Surveillance of active human herpesvirus 6 infection in chinese patients after hematopoietic stem cell transplantation with 3 different methods Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6 MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients Update on human herpesvirus 6 biology, clinical features, and therapy Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation Malignancy-related causes of death in human immunodeficiency virusinfected patients in the era of highly active antiretroviral therapy Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020 High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy Autologous stem cell transplantation for HIV-associated lymphoma High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy Allogeneic hematopoietic stem cell transplantation in HIVpositive patients with hematologic disorders Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Role of surveillance cultures in prevention and treatment of fungal infections Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients Revisiting the source of candidemia: skin or gut? A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation-a prospective, randomized, double-blind study Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997-2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program Candida glabrata erg1 mutant with increased sensitivity to azoles and to low oxygen tension Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation Resistance to echinocandin-class antifungal drugs Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease Results of a randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients Hepatosplenic candidiasisa contraindication to marrow transplantation? Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants Invasive aspergillosis Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study Invasive mold infections in allogeneic bone marrow transplant recipients Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Fusarium infection in hematopoietic stem cell transplant recipients Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact Aerosolized liposomal amphotericin B for the prevention of References invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey Risk factors for pulmonary tuberculosis in bone marrow transplant recipients Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation Tuberculosis in stem cell transplant patients Tuberculosis in blood and marrow transplant recipients Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices Targeted tuberculin testing and treatment of latent tuberculosis infection Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay Interferon gamma release assays for latent tuberculosis infection Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients Tuberculosis in hematopoietic stem cell transplant recipients in Korea Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients Update: adverse event data and revised American Thoracic Society/ CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection-United States General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) Pneumocystis pneumonia transmission between patients with lymphoma Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients Possible transfer of Pneumocystis carinii between immunodeficient patients Possible transfer of Pneumocystis carinii between kidney transplant recipients The compromised host and infection. I. Pneumocystis carinii pneumonia Pneumocystis carinii Pneumonia in a Family Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia Probable motherto-infant transmission of Pneumocystis carinii f. sp. hominis infection Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study Pneumocystis carinii pneumonitis following bone marrow transplantation Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a casecontrol study Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis Desensitization for sulfasalazine skin rash PCP prophylaxis after marrow transplantation: efficacy of trimethoprim-sulfamethoxazole (trim-sulfa), role of trim-sulfa desensitization and iv pentamidine Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review Transmission of toxoplasmosis by leukocyte transfusion Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem cell transplant recipients Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Systemic nocardiosis following allogeneic bone marrow transplantation Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations Nocardiosis after bone marrow transplantation: a Retrospective Study Pulmonary nocardiosis: risk factors and outcomes Risk factors, clinical characteristics, and outcome of nocardia infection in organ transplant recipients: a matched case-control study Strongyloidiasis and other intestinal nematode infections Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect ELISA Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies Strongyloides stercoralis in the immunocompromised population Trypanosoma cruzi in a low-to moderate-risk blood donor population: seroprevalence and possible congenital transmission Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control Strategies for prevention of transfusionassociated Chagas' disease Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole Chagas disease in bone marrow transplantation: an approach to preemptive therapy The stem cell transplant program in Pakistan-the first decade A comparison of the efficacy of insecticide-treated and untreated bed nets in preventing malaria in Gambian children Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC) American Institute of Architects Facility Guidelines Institute, AIA Academy of Architecture for Health, US Department of Health & Human Services. Guidelines for Design and Construction of Health Care Facilities Extrinsic risk factors for pneumonia in the patient at high risk of infection Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies An evaluation of hospital specialventilation-room pressures Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions APIC guideline for selection and use of disinfectants Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit Cryptococcosis in organ transplant recipients: an overview Design and maintenance of hospital ventilation systems and the prevention of airborne infections Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment Nosocomial aspergillosis in outbreak settings Prevention of infections related to construction, renovation, and demolition systems Construction: a model program for infection control compliance The ability of hospital ventilation systems to filter Aspergillus and other fungi following a building implosion Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction Influence of building construction work on Aspergillus infection in a hospital setting A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration Ten-year air sample analysis of Aspergillus prevalence in a university hospital A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling Sampling of Aspergillus spores in air Architectural Design and Indoor Microbial Pollution Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction Viral respiratory tract infections in transplant patients: epidemiology, recognition and management Aspergillus surveillance project at a large tertiary-care hospital Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review The benefits of surface disinfection Aspergillosis due to carpet contamination Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: Implications for upholstery selection in hospitals Hospital Infection Control Practices Advisory Committee Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Outbreak of extended spectrum beta-lactamaseproducing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme Replace hand washing with use of a waterless alcohol hand rub? Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic Alcohol-based hand rub improves compliance with hand hygiene in intensive care units National Antimicrobial Information Network List of EPA registered products Sterilization or Disinfection of Medical Devices: General Purposes. US Department of Health and Human Services Chapter 24: sterilization, disinfection, and antispsis int he hospital Hospital Epidemiology and Infection Control Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings-Minnesota Follow-up on Rhizopus infections associated with Elastoplast bandages-United States An outbreak of cutaneous aspergillosis in a tertiary-care hospital Outbreak of primary cutaneous aspergillosis related to intravenous arm boards Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors Ecological and epidemiological aspects of aspergilli pathogenic for man Isolation of cytomegalovirus from toys and hands in a day care center Rotavirus outbreak on a pediatric oncology floor: possible association with toys Toys-friend or foe? A study of infection risk in a paediatric intensive care unit Bacterial colonization of toys in neonatal intensive care cots Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys ABC's of Safe and Healthy Child Care: An On-Line Handbook for Child Care Providers. US Department of Health and Human Services Guideline for infection control in healthcare personnel Varicella-zoster virus: infection, control, and prevention Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens Infection Control Guidance for the Prevention and Control of Influenza in Acute-Care Facilities Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report Updated clinical practice guidelines for the prevention and treatment of mucositis Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation Hematopoietic Cell Transplantation American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment Palifermin for oral mucositis after intensive therapy for hematologic cancers Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis Oral graft-versus-host disease Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting More than 10 years of unrecognized nosocomial transmission of Legionnaires' disease among transplant patients Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control Sustained transmission of nosocomial Legionnaires disease-Arizona and Ohio A cluster of cases of nosocomial legionnaires disease linked to contaminated hospital decorative water fountain A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus Dutch Workingparty Infection Prevention. Policy for Methicillin-resistant Staphylococcus aureus Management of Multidrug-Resistant Organisms in Healthcare Settings Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper Outbreak of mupirocin-resistant Staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains The prevalence of low-and high-level mupirocin resistance in staphylococci from 19 European hospitals Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin The spread of a mupirocin-resistant/ methicillin-resistant Staphylococcus aureus clone in Kuwait hospitals Giambiaqui-deMarval MM. Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin Vancomycin-intermediate/resistant Staphylococcus aureus laboratory testing algorithm Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC) Performance standards for antimicrobial disk susceptibility testing. Fourteenth informational supplement. NCCLS document Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States Emergence of vancomycin resistance in Staphylococcus aureus Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin Staphylococcus aureus resistant to vancomycin-United States New resistance in Staphylococcus aureus Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bloodstream infections with vancomycin-resistant enterococci An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity Natural history of colonization with vancomycinresistant Enterococcus faecium Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of 'clearance' Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy Controlling vancomycin-resistant enterococci Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? Guidance for control of infections with carbapenem-resistant or carbapenemaseproducing Enterobacteriaceae in acute care facilities Clostridium difficile-associated diarrhea and colitis Clostridium difficile-associated diarrhea Nosocomial acquisition of Clostridium difficile infection Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission Clostridium difficile skin contamination in patients with C. difficileassociated disease Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial Lack of association between the increased incidence of Clostridium difficileassociated disease and the increasing use of alcohol-based hand rubs Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control Environmental control to reduce transmission of Clostridium difficile Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections Community respiratory virus infections in immunocompromised patients with cancer An outbreak of respiratory syncytial virus in a bone marrow transplant center The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness Adenovirus infection in West Bengal. I: persistence of viruses in infants and young children Respiratory syncytial viral infection in children with compromised immune function Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults How contagious are common respiratory tract infections? Prolonged recoverability of desiccated adenovirus type 19 from various surfaces Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro Virus survival on inanimate surfaces Activity of an alcohol-based hand gel against human adeno-, rhino-, and rotaviruses using the fingerpad method Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities Prevalence of rotavirus on high-risk fomites in day-care facilities Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission Environmental monitoring for gastroenteric viruses in a pediatric primary immunodeficiency unit Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo Inactivation of caliciviruses Centers for Disease Control and Prevention (CDC). Norovirus in Healthcare Facilities Fact Sheet. National Center for Preparedness, Detection, and Control of Infectious Diseases Use of a heminested reverse transcriptase PCR assay for detection of astrovirus in environmental swabs from an outbreak of gastroenteritis in a pediatric primary immunodeficiency unit Molecular features of astrovirus associated with a gastroenteritis outbreak in an aged-care centre The changing epidemiology of astrovirus-associated gastroenteritis: a review Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient Viral agents of gastroenteritis. Public health importance and outbreak management Hospital Epidemiology and Infection Control Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Illness transmission in the home: a possible role for alcohol-based hand gels A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home Preventing Cryptosporidiosis: A Guide for People with Compromised Immune System Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America Assessment of the durability of medical examination gloves Performance of latex and nonlatex medical examination gloves during simulated use Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection Effect of handwashing on child health: a randomised controlled trial Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial Handwashing and respiratory illness among young adults in military training The effect of hand hygiene on illness rate among students in university residence halls SARS transmission, risk factors, and prevention in Hong Kong A modified 'cover your cough' campaign prevents exposures of employees to pertussis at a children's hospital Disease associated with potting soil-California Preventing congenital toxoplasmosis Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils Saksenaea vasiformis breast abscess related to gardening injury An infection from a penetrating plant wound Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course Occupational risk assessment of aspergillosis after renal transplantation Coccidioidomycosis in hematopoietic stem cell transplant recipients Coccidioidomycosis in patients who have undergone transplantation Histoplasmosis associated with exploring a batinhabited cave in Costa Rica, 1998-1999 Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk Outbreak of histoplasmosis among industrial plant workers-Nebraska Mycobacterial infections after kidney transplant Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association Exposure to aerosolized bacteria and fungi among collectors of commercial, mixed residential, recyclable and compostable waste Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP) A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of coldadapted influenza virus vaccine Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis Clinical Review for STN 125265/0 Rotarix Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist) Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting ACIP Provisional Recommendations for use of Zoster Vaccine Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings Caring for pets of immunocompromised persons Pet-associated illness Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus Iguana-associated salmonellosis in children Reptile-associated salmonellosis-selected states Iguanas and Salmonella marina infection in children: a reflection of the increasing incidence of reptile-associated salmonellosis in the United States Salmonellosis associated with chicks and ducklings-Michigan and Missouri Animals in schools: a zoonosis threat? Human illness associated with use of veterinary vaccines Who let the dogs out? Infection control did: utility of dogs in health care settings and infection control aspects Lake-associated outbreak of Escherichia coli O157:H7-Illinois Outbreak of cryptosporidiosis associated with a water sprinkler fountain-Minnesota First reported outbreak in the United States of cryptosporidiosis associated with a recreational lake Risks from Food and Water (Drinking and Recreational) Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients Red Book: 2003 Report of the Committee on Infectious Diseases Control of Communicable Disease Manual, 18th edn A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk Diagnostic and therapeutic challenges of childhood brucellosis in a nonendemic country Juice-associated outbreaks of human illness in the United States Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia Handle and Prepare Food Safely Epidemiology of foodborne diseases: a worldwide review The Big Thaw-Safe Defrosting Methods for Consumers Low-microbial diets for patients with granulocytopenia Nutritional support of patients with hematologic malignancies The neutropenic diet: what's the evidence? Outbreaks of Salmonella serotype enteritidis infection associated with eating shell eggs-United States Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials Probiotics for the treatment of women with bacterial vaginosis Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine Travelers's Health: Destinations Outbreak of acute febrile illness among athletes participating in triathlons-Wisconsin and Illinois Outbreak of leptospirosis among white-water rafters-Costa Rica Leptospirosis in 'Eco-Challenge' athletes, Malaysian Borneo Respiratory infections during air travel Travelers' Health: Yellow Book Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine Response to tetanus toxoid immunization after allogeneic bone marrow transplantation Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation Immunity to poliovirus and immunization with inactivated poliovaccine after autologous bone marrow transplantation Polysaccharide conjugate vaccine responses in bone marrow transplant patients Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections Infection with varicella-zoster virus after marrow transplantation Clinical features of measles in immunocompromised children Measles in bone marrow transplant recipients during an outbreak in Sao Paulo A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients Influenza infections after hematopoietic stem cell transplantation Immunological reconstitution following hematopoietic stem cell transplantation Immunological reconstitution after hemopoietic stem cell transplantation Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients Development of functional Haemophilus influenzae type b antibodies after vaccination Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial Use of the tetanus toxoid, reduced dose diphtheria and pertussis vaccine (Tdap) in allogeneic transplant (alloHCT) recipients [abstract Pertussis Immunity and Response to tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) following autologous peripheral blood stem cell transplantation Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients Immunogenicity of the tetravalent proteinconjugated meningococcal vaccine in recipients of related and unrelated allogeneic hematopoietic cell transplants (HCT) Immune reconstitution following hematopoietic stem-cell transplantation Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T celldepleted allogeneic stem cell transplantation Factors associated with early molecular remission after T celldepleted allogeneic stem cell transplantation for chronic myelogenous leukemia Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning Low B cell and monocyte counts on day 80 are associated with high infection rates between day 100 and 365 after allogeneic marrow transplantation Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome Immune monitoring with iTAg (TM) MHC tetramers for prediction of recurrent or persistent CMV infection in allogeneic stem cell transplant recipients: a prospective multicenter clinical trial Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices American Academy of Pediatrics. Rabies. In: LK Pickering (ed) Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) Report of the Committee on Infectious Diseases Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA Human intravenous immunoglobulin in primary and secondary antibody deficiencies American Academy of Pediatrics. Passive Immunization. In: LK Pickering Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation Ribavirin for SARS in children Ivermectin for human strongyloidiasis and other intestinal helminths Reye's syndrome in the United States from 1981 through 1997 Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations Report of the Committee on Infectious Diseases